SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Theriva Biologics says Nature Medicine publishes VIRAGE Phase 2b results

Peer-reviewed publication covers VCN-01 in metastatic pancreatic cancer and reports improved survival-related outcomes versus chemotherapy alone.

TOVX.A